I look forward to enrolling patients into the PEAK-1 trial as soon as it is open.” “The initial data for casdatifan plus cabozantinib in the ARC-20 study have already exceeded the historic ...

SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of ...

26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases Deep and durable ...

May 31, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living ...

module to inject pre-designed false data into a subset of measurements without being observed. To mitigate the threats, this paper develops a real-time FDIAs identification mechanism for AC state ...

For example, a building products distributor ... forecasts that sales will increase 5% based on historical data. Then, a new competitor enters the market and takes away market share. Static ...

--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with ...

Treatment of posthepatectomy liver failure remains difficult, and mortality is substantial. Preoperative evaluation of future remnant liver (FRL) function is therefore important to determine whether a ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.